Insmed
INSM
INSM
100 hedge funds and large institutions have $998M invested in Insmed in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 31 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 101 → 100 (-1)
1.5% less ownership
Funds ownership: 93.41% → 91.9% (-1.5%)
76% less call options, than puts
Call options by funds: $5.44M | Put options by funds: $22.9M
Holders
100
Holding in Top 10
1
Calls
$5.44M
Puts
$22.9M
Top Buyers
| 1 | +$81.9M | |
| 2 | +$6.27M | |
| 3 | +$5.28M | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$3.87M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.04M |
Top Sellers
| 1 | -$8.6M | |
| 2 | -$5.17M | |
| 3 | -$4.86M | |
| 4 |
Citigroup
New York
|
-$4.29M |
| 5 |
NC
Nexthera Capital
New York
|
-$4.26M |